Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Madjar

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Chemical Research in Toxicology|April 13, 2022
Classification of Developmental Toxicants in a Human iPSC Transcriptomics-Based TestAnna Cherianidou, Florian Seidel, Franziska Kappenberg, et al.
Cells|November 11, 2022
High Accuracy Classification of Developmental Toxicants by In Vitro Tests of Human Neuroepithelial and Cardiomyoblast DifferentiationFlorian Seidel, Anna Cherianidou, Franziska Kappenberg, et al.
Cancer Research|June 28, 2017
Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian CarcinomaRosemarie Marchan, Bettina Büttner, Jörg Lambert, et al.
Archives of Toxicology|November 13, 2019
Development of a neural rosette formation assay (RoFA) to identify neurodevelopmental toxicants and to characterize their transcriptome disturbancesNadine Dreser, Katrin Madjar, Anna-Katharina Holzer, et al.
JCI Insight|October 5, 2016
Profiling cancer testis antigens in non-small-cell lung cancerDijana Djureinovic, Björn M Hallström, Masafumi Horie, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2023
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growthMagdalena Keller, Katharina Rohlf, Annika Glotzbach, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.
International Journal of Cancer|January 18, 2019
LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancerCristina Cadenas, Sonja Vosbeck, Karolina Edlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION TrialKarolina Edlund, Katrin Madjar, Antje Lebrecht, et al.
Archives of Toxicology|November 17, 2014
Toxicogenomics directory of chemically exposed human hepatocytesMarianna Grinberg, Regina M Stöber, Karolina Edlund, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Chemical Research in Toxicology|April 13, 2022
Classification of Developmental Toxicants in a Human iPSC Transcriptomics-Based TestAnna Cherianidou, Florian Seidel, Franziska Kappenberg, et al.
Cells|November 11, 2022
High Accuracy Classification of Developmental Toxicants by In Vitro Tests of Human Neuroepithelial and Cardiomyoblast DifferentiationFlorian Seidel, Anna Cherianidou, Franziska Kappenberg, et al.
Cancer Research|June 28, 2017
Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian CarcinomaRosemarie Marchan, Bettina Büttner, Jörg Lambert, et al.
Archives of Toxicology|November 13, 2019
Development of a neural rosette formation assay (RoFA) to identify neurodevelopmental toxicants and to characterize their transcriptome disturbancesNadine Dreser, Katrin Madjar, Anna-Katharina Holzer, et al.
JCI Insight|October 5, 2016
Profiling cancer testis antigens in non-small-cell lung cancerDijana Djureinovic, Björn M Hallström, Masafumi Horie, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2023
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growthMagdalena Keller, Katharina Rohlf, Annika Glotzbach, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.
International Journal of Cancer|January 18, 2019
LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancerCristina Cadenas, Sonja Vosbeck, Karolina Edlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION TrialKarolina Edlund, Katrin Madjar, Antje Lebrecht, et al.
Archives of Toxicology|November 17, 2014
Toxicogenomics directory of chemically exposed human hepatocytesMarianna Grinberg, Regina M Stöber, Karolina Edlund, et al.
Pageof 3